Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Granulocyte-colony-stimulating factor
DRUG
2 trials
Sponsors
Goethe University
, Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie
Conditions
Adult Acute Lymphocytic Leukemia
Diffuse Large B-Cell Lymphoma
POOR PROGNOSIS
Phase 2
Rituximab in Addition to Chemotherapy With Autologous Stem Cell Transplantation as Treatment Diffuse Large B-Cell Lymphoma
Completed
NCT00556127
Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie
Diffuse Large B-Cell Lymphoma, POOR PROGNOSIS
Start: 2002-06-30
End: 2006-09-30
Updated: 2007-11-09
Phase 4
German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Completed
NCT00198978
Goethe University
Adult Acute Lymphocytic Leukemia
Start: 2003-01-31
End: 2014-06-30
Updated: 2023-03-20
Related Papers
S114: OUTCOME OF OLDER PATIENTS (>55 YRS) WITH NEWLY DIAGNOSED PH/BCR:ABL POSITIVE ALL PROSPECTIVELY TREATED ACCORDING TO PEDIATRIC-BASED, AGE-ADAPTED GMALL PROTOCOLS
HemaSphere
2023-08-01
Outcome of 841 Older Patients (>55 yrs) with Newly Diagnosed Ph/BCR-ABL Negative ALL Prospectively Treated According to Pediatric-Based, Age-Adapted GMALL Protocols
Blood
2022-11-15
16 citations
Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL.
2012-09-28
342 citations